Mark Vrana
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
-
- T-cell and B-cell Immunology
Papers in
-
- Glycosylation and Glycoproteins Research 8
-
- Microbial Metabolites in Food Biotechnology 6
- Co-authors
- Michael Potter (5 shared papers)Stuart Rudikoff (5 shared papers)R Lieberman (2 shared papers)William Humphrey (2 shared papers)Hollon W. Farr (1 shared paper)George F. Gray (1 shared paper)E. B. Mushinski (2 shared papers)Michael P. Lardis (2 shared papers)
- Journals
- The Journal of Immunology (3 papers)Cancer (2 papers)The Journal of Experimental Medicine (2 papers)Scientific Reports (1 paper)Journal of Surgical Oncology (1 paper)
- Partner nations
- United States
In The Last Decade
Mark Vrana
16 papers receiving 353 citations
Peers
Comparison fields: 5 of 64
- Radiology, Nuclear Medicine and Imaging 155
- Immunology 122
- Complementary and Manual Therapy 9
- Neurology 61
- Immunology and Allergy 24
Countries citing papers authored by Mark Vrana
This map shows the geographic impact of Mark Vrana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Vrana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Vrana more than expected).
Fields of papers citing papers by Mark Vrana
This network shows the impact of papers produced by Mark Vrana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Vrana. The network helps show where Mark Vrana may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Vrana, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1975 | 82 | |
| 2 | 1973 | 74 | |
| 3 | 1972 | 48 | |
| 4 | 2018 | 28 | |
| 5 | 2010 | 27 | |
| 6 | 1978 | 24 | |
| 7 | 1977 | 21 | |
| 8 | 1976 | 21 | |
| 9 | The structural basis of a hapten-inhibitable kappa-chain idiotype. | 1979 | 19 |
| 10 | 1979 | 16 | |
| 11 | 1971 | 15 | |
| 12 | 1977 | 12 | |
| 13 | 1978 | 10 | |
| 14 | 1977 | 10 | |
| 15 | 1978 | 5 | |
| 16 | 1980 | 3 |
About Mark Vrana
Mark Vrana is a scholar working on Molecular Biology, Nutrition and Dietetics, Organic Chemistry, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 16 papers that have together received 415 indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (8 papers), Microbial Metabolites in Food Biotechnology (6 papers), Carbohydrate Chemistry and Synthesis (5 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Multiple Myeloma Research and Treatments (3 papers), Polysaccharides and Plant Cell Walls (2 papers), Cancer Treatment and Pharmacology (1 paper) and Meningioma and schwannoma management (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (155 citations), Immunology (122 citations), Complementary and Manual Therapy (9 citations), Neurology (61 citations) and Immunology and Allergy (24 citations). Mark Vrana has collaborated with scholars based in United States. Frequent co-authors include Michael Potter, Stuart Rudikoff, R Lieberman, William Humphrey, Hollon W. Farr, George F. Gray, E. B. Mushinski, Michael P. Lardis, Cornelis P.J. Glaudemans and Lloyd J. Old. Their work appears in journals such as The Journal of Immunology, Cancer, The Journal of Experimental Medicine, Scientific Reports and Journal of Surgical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.